Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
06/2010
06/23/2010CN101747280A Method for preparing detomidine and the intermediate thereof
06/23/2010CN101747279A Method for preparing optically active compound
06/23/2010CN101747278A Method for synthesizing 1-chloroformyl-3-methyl sulfonyl-2-imidazo flavanone
06/23/2010CN101747243A Ionic liquid prepared through diimine (vikane) and (perfluoroalkglsulfonyl fluorosulfonyl group) imine alkali salt
06/23/2010CN101215262B Ionic liquid and its preparing process and use
06/23/2010CN101054366B Method of synthesizing 1-methyl hydantoin
06/22/2010US7741493 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives; antiinflammatory agent, neurodegenerative diseases; inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease
06/22/2010US7741371 antiandrogens useful for suppressing spermatogenesis, treating hormone related conditions and prostate cancer; hormone inhibitors
06/22/2010US7741356 Compounds as opioid receptor modulators
06/22/2010US7741346 Vision defects; anticancer agents; antitumor agents
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction
06/22/2010CA2428603C Prevention of development of dyskinesias with an alfa 2-adrenoceptor antagonist
06/22/2010CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
06/17/2010WO2010066847A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
06/17/2010WO2010066658A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
06/17/2010WO2010048207A3 Aryl gpr120 receptor agonists and uses thereof
06/17/2010WO2010028189A3 Compounds, compositions and methods of using same for modulating uric acid levels
06/17/2010WO2010009402A9 Nilotinib intermediates and preparation thereof
06/17/2010US20100152465 Functionalized Ionic Liquids, and Methods of Use Thereof
06/17/2010US20100152460 Process for the preparation of opioid modulators
06/17/2010US20100152459 Novel histidine derivatives
06/17/2010US20100152264 3- to 7-membered 1,3-diaza-4-oxo-heterocyclic derivatives capable of releasing active aldehydes or ketones
06/17/2010US20100152261 Novel nitrogen-containing heterocyclic compound
06/17/2010US20100152220 Indene derivatives as pharmaceutical agents
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152148 Novel compounds
06/17/2010US20100151351 monomers and polymers carrying imidazole and benzimidazole groupings, and proton exchange membrane containing the same for the production of a fuel cell
06/17/2010US20100148126 Genomic sequencing using modified protein pores and ionic liquids
06/16/2010EP2196460A1 Sulfonic acid salt compound of 4-carbamoyl-5-hydroxy-imidazole derivative
06/16/2010EP2196459A1 5-membered heterocyclic compound
06/16/2010EP2196453A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents
06/16/2010EP1756085B1 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
06/16/2010EP1651958B1 Novel chemiluminescent compounds and their use
06/16/2010CN101743227A Novel histidine derivative
06/16/2010CN101735168A P-sulfamyl benzylidene cyclic ketone compounds, preparation method and application thereof
06/16/2010CN101108861B Salts comprising cyanoborate anions
06/16/2010CN101099462B Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737284 chemical condensation process to produce a chemical intermediates for antitumor agents; industrial scale, and provide good yields; simplification; efficiency
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/15/2010CA2441309C Biguanide derivatives
06/15/2010CA2440648C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
06/10/2010WO2010064631A1 Photobase generator
06/10/2010WO2010063953A2 Novel amino c-xyloside compounds, and cosmetic use
06/10/2010WO2010063721A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
06/10/2010WO2010036404A3 Novel retinamide retinoic acid metabolism blocking agents
06/10/2010WO2010025370A3 Preparation of ranolazine
06/10/2010US20100144816 Functionally selective alpha2c adrenoreceptor agonists
06/10/2010US20100144814 Novel 4-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
06/10/2010US20100144813 Novel 4-heteroarylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
06/10/2010US20100144801 Muscarinic receptor antagonists
06/10/2010US20100144626 Treatment of Multi-Drug Resistant Bacterial Infections
06/10/2010US20100143981 Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase
06/10/2010US20100143805 Nitroxides for lithium-ion batteries
06/10/2010CA2744300A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
06/09/2010EP2193122A1 Imidazole derivatives
06/09/2010CN1898187B Fluorinating agent and method for producing fluorine-containing compound using same
06/09/2010CN101730685A Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid
06/09/2010CN101723976A Ionic liquids comprising fluoralkyltriffluoroborate anions
06/09/2010CN101723969A Nitro imidazole derivate used for treatment
06/09/2010CN101723928A Ion liquid and preparation technology thereof
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101723899A Imidazoline derivative and preparation method thereof as well as petroleum refining auxiliary agent containing compound
06/09/2010CN101182308B Imidazole chiral ionic liquids containing double function groups as well as preparation method and uses thereof
06/09/2010CN101143848B Imidazole-like ionic salt with electron donor-acceptor structure, preparation method and use thereof
06/09/2010CN101041637B Chiral amine protonic acid salt containing imidazole sulfur ether structure and preparation method and usage thereof
06/09/2010CN101012199B Method for synthesizing imidazole butanol
06/08/2010US7732617 Tocopherol derivatives and uses thereof
06/08/2010CA2575902C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide
06/03/2010WO2010062686A2 Imidazol-4-one and imidazole-4-thione compounds
06/03/2010WO2010061579A1 Novel crosslinked hexaaryl bisimidazole compound and derivative thereof, method for producing the compound and precursor compound to be used in the production method
06/03/2010WO2010030891A3 Aryl guanidine f1f0-atpase inhibitors and related methods
06/03/2010WO2009154300A3 Heterocyclic compound and use thereof
06/03/2010US20100137613 Process for eprosartan
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137444 Ketone compounds and compositions for cholesterol management and related uses
06/03/2010US20100137385 Insecticidal Substituted Amino Heterocyclic and Heteroaryl Derivatives
06/03/2010US20100137349 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
06/03/2010US20100137323 Benzo-fused compounds for use in treating metabolic disorders
06/02/2010EP2190823A1 Halosubstituted aryloxyalkylimidazolines for use as pesticides
06/02/2010EP2190822A2 5-membered heterocyclic compounds as proton pump inhibitors
06/02/2010EP2190821A1 Fluorine-containing organosulfur compound and pesticidal composition comprising the same
06/02/2010EP1828142B1 Method for producing onium alkyl sulfates with a low halogenide content
06/02/2010EP1658263B1 Novel aminobenzophenone compounds
06/02/2010CN1938280B Thiourea compositions and uses thereof
06/02/2010CN101717373A Diaryl urea derivative and application thereof
06/02/2010CN101717368A Method and process thereof for preparing imidazole ionic liquid under microwave condition
06/02/2010CN101717367A Preparation method of N, N'-dialkyl cyclic urea type derivative
06/01/2010US7728147 catalytic hydrogenation in aqueous solution comprising hydrochloric acid, concentrating, distilling; avoids use of isopropanol and ethylacetate solvents; animal sedation
06/01/2010US7728028 Substituted imidazoline compounds
06/01/2010US7728027 reacting 2-bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone with 1-(tert-butoxycarbonyl)-L-proline, then treating the product with ammonium acetate and deprotection to form chemical intermediates for viricides; cost efficiency; industrial scale
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010CA2415169C Novel c-4 substituted retinoids
06/01/2010CA2396888C 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
05/2010
05/27/2010WO2010058995A1 Electroluminescent device using the electroluminescent compounds
05/27/2010WO2010058129A2 Method for manufacturing methylmercaptopropionaldehyde and methionine using renewable raw materials
05/27/2010WO2010000372A3 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
05/27/2010WO2009129387A3 Cationic lipids and uses thereof
05/27/2010US20100130743 Heterocycle-substituted, n-phenyl-phthalamide derivatives, related compounds and their use as insecticides
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 345